Torrent Pharma delivered a textbook quarter — revenues up 18 per cent year-on-year to Rs 33 billion, profits climbing 26 per cent to Rs 6.4 billion, and EBITDA margins nudging up 40 basis points to 32.9 per cent. In the ordinary course of business, that would have been the headline.Continue Reading

Brokerages lift targets after earnings beat, but watch Bharat Electronics valuation India’s state-owned defence electronics manufacturer Bharat Electronics delivered a quarter that had analysts scrambling to revise their models upward. The company’s third-quarter performance beat expectations across every metric, prompting both Motilal Oswal and Nirmal Bang to raise their targetContinue Reading

JM Financial analysts initiate coverage with REDUCE rating as India’s value commerce champion trades at premium valuations post-IPO JM Financial just dropped their first report on Meesho after the company’s December 2025 listing, and the thesis is fascinating: Meesho has built something genuinely important for Indian e-commerce, but the stockContinue Reading